Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Hydroxychloroquine × Clear all

Phase

Status

Terminated 2 Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urologic Diseases 1 Pancreatic Neoplasms 1 Nephritis 1 Neoplasms 1 Melanoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Kidney Diseases 1 Immune System Diseases 1 Hypoxia 1 Glomerulonephritis, IGA 1 Glomerulonephritis 1 Carcinoma, Non-Small-Cell Lung 1 COVID-19 1 Breast Neoplasms 1 Autoimmune Diseases 1

Interventions

Drug Therapy 16 Exercise 15 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 9 Radiotherapy 9 pembrolizumab 8 Paclitaxel 8 Dexamethasone 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 6 Interviews as Topic 6 Fluorouracil 6 Cisplatin 6 Biopsy 6 apatinib 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Gemcitabine 5 Cyclophosphamide 5 atezolizumab 4 Therapeutics 4 Rivaroxaban 4 Radiosurgery 4 Positron Emission Tomography Computed Tomography 4 Nutritional Status 4 Methylprednisolone 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04341207 2020-04-10

ONCOVID

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡